Ready Partner to Address the Zika Public Health Crisis

Syneos Health is committed to improving global health and, as part of that mission, is poised to be the CRO partner of choice for clinical research in this area. We believe our organizational focus on therapeutic alignment supports this commitment. Each therapeutic area is represented within Syneos Health by a therapeutic area leader and staffed with medical specialists, project management staff and clinical operations staff to the level of clinical research associates.

This structure allows for our Infectious Disease and Vaccines teams to work in the area of their passion, develop a firm grasp of the best practices to apply study after study and be surrounded by supportive and knowledgeable colleagues that they work with habitually.

We believe that prioritizing investigational site needs and developing close relationships with the investigators and their research teams is critical to conducting the highest quality clinical research. This is evidenced by the CenterWatch awards for “Best CRO to Work With” in two consecutive rounds as voted by clinical study investigators and support for the Society for Clinical Research Sites (SCRS).

It is our belief that careful clinical investigation in the face of chaotic circumstances is essential to understanding how to contain the current public health crisis. Our combination of therapeutic alignment and investigator site intimacy helps us deliver on this goal.

We are ready to partner and assist in the effort to better understand Zika virus and are determined to ensure quality and robust data collection in this challenging setting. We are anxious to leverage our combination of experience, capabilities, global footprint and commitment to global health against this crisis in collaboration with our clinical and public health colleagues.

Click here to read our zika virus white paper